Announce Date | 02/25/2025 |
EPS Normalized Actual | $-2.54 (Miss by $-1.01) |
EPS GAAP Actual | $-2.54 (Miss by $-1.01) |
Revenue Actual | $2.3737B |
Revenue Surprise | Beat by $2373.7M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.4001 |
EPS GAAP Estimate | $0.4001 |
Revenue Estimate | $3.121724935B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.1 | 120.9 | 0.08110835 | 0.11827 | 1 |
Dec 2028 | -0.25 | -48.36 | -0.3205 | -0.17736 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -6.54 | -6.54 | 2.3737B | -70.58% | 2373.7M |
FQ3 2024 (Sep 2024) | -1.2 | -1.2 | 2.8292B | -67.84% | 2829.2M |
FQ2 2024 (Jun 2024) | -0.58 | -0.58 | 3.4217B | -22.62% | 3421.7M |
FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 3.2276B | -21.59% | 3227.6M |
FQ4 2023 (Dec 2023) | 0 | 0 | 4.0491B | -10.62% | 4049.1M |
FQ3 2023 (Sep 2023) | 1.98 | 1.98 | 4.7484B | -12.14% | 4748.4M |
FQ2 2023 (Jun 2023) | -0.13 | -0.13 | 4.1956B | -42.59% | 4195.6M |
FQ1 2023 (Mar 2023) | 0.96 | 0.96 | 3.9243B | 100% | 3924.3M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.4001
Consensus Revenue Estimates
3.121724935B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.891 | -- | 0.72981 | 1.10225 | 2 |
FQ2 2027 (Jun 2027) | 0.75725 | -- | 0.62026 | 0.93679 | 2 |
FQ1 2027 (Mar 2027) | -0.0314 | -- | -0.03884479 | -0.02571943 | 2 |
FQ4 2026 (Oct 2026) | 0.67013 | -- | 0.48367 | 0.91267 | 3 |
FQ3 2026 (Jul 2026) | 0.75005 | -- | 0.54135 | 1.02152 | 5 |
FQ2 2026 (Jun 2026) | 0.21827 | -- | 0.17162 | 0.28982 | 4 |
FQ1 2026 (Mar 2026) | 0.1942 | -- | 0.15269 | 0.25786 | 5 |
FQ4 2025 (Oct 2025) | 0.69695 | 1038.37 | 0.50303 | 0.9492 | 4 |
FQ3 2025 (Jul 2025) | 0.71717 | 267.32 | 0.51762 | 0.97674 | 6 |
FQ2 2025 (Jun 2025) | 0.4001 | 244.96 | 0.31458 | 0.53126 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.14B | -- | 3.56B | 4.89B | 2 |
FQ2 2027 (Jun 2027) | 3.93B | -- | 3.39B | 4.65B | 2 |
FQ1 2027 (Mar 2027) | 3.74B | -- | 3.22B | 4.42B | 2 |
FQ4 2026 (Oct 2026) | 3.26B | -- | 2.57B | 4.17B | 2 |
FQ3 2026 (Jul 2026) | 3.23B | -- | 2.54B | 4.13B | 2 |
FQ2 2026 (Jun 2026) | 3.25B | -- | 2.71B | 4.07B | 2 |
FQ1 2026 (Mar 2026) | 3.2B | -- | 2.67B | 4B | 2 |
FQ4 2025 (Oct 2025) | 3B | 20.95 | 2.36B | 3.84B | 1 |
FQ3 2025 (Jul 2025) | 2.98B | 4.96 | 2.34B | 3.81B | 1 |
FQ2 2025 (Jun 2025) | 3.12B | -9.61 | 2.61B | 3.91B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -6.54 | -6.54 | 100% | |
FQ3 2024 (Sep 2024) | -1.2 | -1.2 | 100% | |
FQ2 2024 (Jun 2024) | -0.58 | -0.58 | 100% | |
FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.98 | 1.98 | 100% | |
FQ2 2023 (Jun 2023) | -0.13 | -0.13 | 100% | |
FQ1 2023 (Mar 2023) | 0.96 | 0.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.37B | $2373.7M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.83B | $2829.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.42B | $3421.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.23B | $3227.6M | 100% |
FQ4 2023 (Dec 2023) | $0B | $4.05B | $4049.1M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.75B | $4748.4M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.2B | $4195.6M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.92B | $3924.3M | 100% |